Towards developmental models of psychiatric disorders in zebrafish

Frontiers in Neural Circuits

Volumn , Issue APR 2013, 2013, Pages

  Norton, William ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Autism spectrum disorder; Development; Mental retardation; Psychiatric disorders; Schizophrenia; Zebrafish

Indexed keywords

ATOMOXETINE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; METHYLPHENIDATE; PENTETRAZOLE;

ATTENTION DEFICIT DISORDER; AUTISM; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DISEASE MODEL; DISEASE ONSET; DISRUPTED IN SCHIZOPHRENIA 1 GENE; DNA POLYMORPHISM; DRUG EXPOSURE; DRUG SCREENING; EMBRYO DEVELOPMENT; ENDOPHENOTYPE; ENVIRONMENTAL FACTOR; FRAGILE X MENTAL RETARDATION 1 GENE; GENE; GENE MUTATION; GENERAL PATHOLOGICAL PARAMETERS; GENETIC ASSOCIATION; GENETIC MANIPULATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; KCDT13 GENE; LATROPHILIN3 GENE; LOSS OF FUNCTION MUTATION; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; REVIEW; SCHIZOPHRENIA; SHANK3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; X LINKED MENTAL RETARDATION; XLMR GENE; ZEBRA FISH;

EID: 84876068346     PISSN: 16625110     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncir.2013.00079     Document Type: Review

References (155)

1. Amacher, S. L. (2008). Emerging gene knockout technology in zebrafish: zinc-finger nucleases. Briefings in functional genomics & proteomics 7, 460-4.
2. Amir-Zilberstein, L., Blechman, J., Sztainberg, Y., Norton, W., Reuveny, A., Borodovsky, N., Tahor, M., Bonkowsky, J. L., Bally-Cuif, L., Chen, A., et al. (2011). Homeodomain protein Otp and activity-dependent splicing modulate neuronal adaptation to stress. Neuron.
3. Arcos-Burgos, M., Jain, M., Acosta, M. T., Shively, S., Stanescu, H., Wallis, D., Domene, S., Velez, J. I., Karkera, J. D., Balog, J., et al. (2010). A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular psychiatry 15, 1053-66.
4. Arime, Y., Kubo, Y., and Sora, I. (2011). Animal models of attention-deficit/hyperactivity disorder. Biological & pharmaceutical bulletin 34, 1373-6.
5. Arnsten, A. F. (2007). Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 17 Suppl 1, 16-15.
6. Aspatwar, A., Tolvanen, M. E., Jokitalo, E., Parikka, M., Ortutay, C., Harjula, S. K., Ramet, M., Vihinen, M., and Parkkila, S. (2012). Abnormal cerebellar development and ataxia in CARP VIII morphant zebrafish. Human molecular genetics. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23087022.
7. Bailey, A. J., Braeutigam, S., Jousmaki, V., and Swithenby, S. J. (2005). Abnormal activation of face processing systems at early and intermediate latency in individuals with autism spectrum disorder: a magnetoencephalographic study. The European journal of neuroscience 21, 2575-85.
8. Banaschewski, T., Becker, K., Scherag, S., Franke, B., and Coghill, D. (2010). Molecular genetics of attention-deficit/hyperactivity disorder: an overview. European child & adolescent psychiatry 19, 237-57.
9. Baraban, S. C. (2007). Emerging epilepsy models: insights from mice, flies, worms and fish. Current opinion in neurology 20, 164-8.
10. Barkley, R. A., Fischer, M., Smallish, L., and Fletcher, K. (2006). Young adult outcome of hyperactive children: adaptive functioning in major life activities. Journal of the American Academy of Child and Adolescent Psychiatry 45, 192-202.
11. Baxendale, S., Holdsworth, C. J., Meza Santoscoy, P. L., Harrison, M. R., Fox, J., Parkin, C. A., Ingham, P. W., and Cunliffe, V. T. (2012). Identification of compounds with anti699 convulsant properties in a zebrafish model of epileptic seizures. Disease models & mechanisms 5, 773-84.
12. Ben-David, E., and Shifman, S. (2012). Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS genetics 8, e1002556.
13. Berquin, P. C., Giedd, J. N., Jacobsen, L. K., Hamburger, S. D., Krain, A. L., Rapoport, J. L., and Castellanos, F. X. (1998). Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 50, 1087-93.
14. Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F., Kelley, A. E., Schmeichel, B., Hamilton, C., and Spencer, R. C. (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological psychiatry 60, 1111-20.
15. Blader, P., and Strahle, U. (1998). Ethanol impairs migration of the prechordal plate in the zebrafish embryo. Developmental biology 201, 185-201.
16. Blaker-Lee, A., Gupta, S., McCammon, J. M., De Rienzo, G., and Sive, H. (2012). Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes. Disease models & mechanisms 5, 834-51.
17. Braff, D., Schork, N. J., and Gottesman, I. (2007). Endophenotyping schizophrenia. The American journal of psychiatry 164, 705-7.
18. Bretaud, S., Lee, S., and Guo, S. (2004). Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicology and teratology 26, 857-64.
19. Brockschmidt, A., Filippi, A., Charbel Issa, P., Nelles, M., Urbach, H., Eter, N., Driever, W., and Weber, R. G. (2011). Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model. Human genetics 130, 645-55.
20. Den Broeder, M. J., Van der Linde, H., Brouwer, J. R., Oostra, B. A., Willemsen, R., and Ketting, R. F. (2009). Generation and characterization of FMR1 knockout zebrafish. PloS one 4, e7910.
21. Burgess, H. A., and Granato, M. (2007). Modulation of locomotor activity in larval zebrafish during light adaptation. The Journal of experimental biology 210, 2526-39.
22. Bush, G. (2010). Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology 35, 278-300.
23. Buske, C., and Gerlai, R. (2011). Early embryonic ethanol exposure impairs shoaling and the dopaminergic and serotoninergic systems in adult zebrafish. Neurotoxicology and teratology 33, 698-707.
24. Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Vaituzis, A. C., Dickstein, D. P., Sarfatti, S. E., Vauss, Y. C., Snell, J. W., Lange, N., et al. (1996). Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Archives of general psychiatry 53, 607-16.
25. Chen, J., Patel, R., Friedman, T. C., and Jones, K. S. (2010). The Behavioral and Pharmacological Actions of NMDA Receptor Antagonism are Conserved in Zebrafish Larvae. International journal of comparative psychology / ISCP; sponsored by the International Society for Comparative Psychology and the University of Calabria 23, 82-90.
26. Cheng, Y. C., Scotting, P. J., Hsu, L. S., Lin, S. J., Shih, H. Y., Hsieh, F. Y., Wu, H. L., Tsao, C. L., and Shen, C. J. (2012). Zebrafish rgs4 is essential for motility and axonogenesis mediated by Akt signaling. Cellular and molecular life sciences: CMLS. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23052218.
27. Choudhry, Z., Sengupta, S. M., Grizenko, N., Fortier, M. E., Thakur, G. A., Bellingham, J., and Joober, R. (2012). LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. Journal of child psychology and psychiatry, and allied disciplines 53, 892-902.
28. Comings, D. E., Wu, S., Chiu, C., Ring, R. H., Gade, R., Ahn, C., MacMurray, J. P., Dietz, G., and Muhleman, D. (1996). Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. American journal of medical genetics 67, 264-88.
29. Cook, E. H., and Scherer, S. W. (2008). Copy-number variations associated with neuropsychiatric conditions. Nature 455, 919-23.
30. Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., and Leventhal, B. L. (1995). Association of attention-deficit disorder and the dopamine transporter gene. American journal of human genetics 56, 993-8.
31. Cooper, B. (2001). Nature, nurture and mental disorder: old concepts in the new millennium. BJP 178, s91-s101.
32. Cortese, S., Konofal, E., Lecendreux, M., Arnulf, I., Mouren, M.-C., Darra, F., and Dalla Bernardina, B. (2005). Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 28, 1007-1013.
33. Curado, S., Anderson, R. M., Jungblut, B., Mumm, J., Schroeter, E., and Stainier, D. Y. (2007). Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies. Dev Dyn 236, 1025-35.
34. Curran, S., Mill, J., Tahir, E., Kent, L., Richards, S., Gould, A., Huckett, L., Sharp, J., Batten, C., Fernando, S., et al. (2001). Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Molecular psychiatry 6, 425-8.
35. Domene, S., Stanescu, H., Wallis, D., Tinloy, B., Pineda, D. E., Kleta, R., Arcos-Burgos, M., Roessler, E., and Muenke, M. Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility. Am J Med Genet B Neuropsychiatr Genet 156B, 11-8.
36. Eaton, L. (2008). Healthcare Commission's standards of psychiatric care. Mental health today, 5.
37. Ebstein, R. P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E. R., Nemanov, L., Katz, M., and Belmaker, R. H. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature genetics 12, 78-80.
38. Echevarria, D. J., Jouandot, D. J., and Toms, C. N. (2011). Assessing attention in the zebrafish: Are we there yet? Progress in neuro-psychopharmacology & biological psychiatry 35, 1416-20.
39. Eddins, D., Cerutti, D., Williams, P., Linney, E., and Levin, E. D. (2010). Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicology and teratology 32, 99-108.
40. Einat, H., Manji, H. K., and Belmaker, R. H. (2003). New approaches to modeling bipolar disorder. Psychopharmacology bulletin 37, 47-63.
41. Elia, J., Gai, X., Xie, H. M., Perin, J. C., Geiger, E., Glessner, J. T., D'Arcy, M., deBerardinis, R., Frackelton, E., Kim, C., et al. (2009). Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Molecular psychiatry 15, 637-46.
42. Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., and Sklar, P. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological psychiatry 57, 1313-23.
43. Farokhashtiani, T., Mirabzadeh, A., Olad Nabi, M., Magham, Z. G., Khorshid, H. R., Najmabadi, H., and Ohadi, M. (2011). Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation. Progress in neuro-psychopharmacology & biological psychiatry 35, 541-4.
44. Fernandes, Y., and Gerlai, R. (2009). Long-term behavioral changes in response to early developmental exposure to ethanol in zebrafish. Alcoholism, clinical and experimental research 33, 601-9.
45. Fero, K., Yokogawa, T., and Burgess, H. A. (2010). The behavioral repertoire of larval zebrafish. Zebrafish Models in Neurobehavioral Research.
46. Fetcho, J. R., and Liu, K. S. (1998). Zebrafish as a model system for studying neuronal circuits and behavior. Annals of the New York Academy of Sciences 860, 333-45.
47. Flynn, S. W., Lang, D. J., Mackay, A. L., Goghari, V., Vavasour, I. M., Whittall, K. P., Smith, G. N., Arango, V., Mann, J. J., Dwork, A. J., et al. (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Molecular psychiatry 8, 811-20.
48. Frazer, K. A., Murray, S. S., Schork, N. J., and Topol, E. J. (2009). Human genetic variation and its contribution to complex traits. Nature reviews 10, 241-51.
49. Friedrich, T., Lambert, A. M., Masino, M. A., and Downes, G. B. (2012). Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease. Disease models & mechanisms 5, 248-58.
50. Fujimoto, E., Stevenson, T. J., Chien, C. B., and Bonkowsky, J. L. (2011). Identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification. Developmental biology 352, 393-404.
51. Gauthier, J., Champagne, N., Lafreniere, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Cote, M., Noreau, A., et al. (2010). De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 107, 7863-8.
52. Geschwind, D. H. (2008). Autism: many genes, common pathways? Cell 135, 391-5.
53. Geschwind, D. H. (2011). Genetics of autism spectrum disorders. Trends in cognitive sciences 15, 409-16.
54. Geschwind, D. H., and Levitt, P. (2007). Autism spectrum disorders: developmental disconnection syndromes. Current opinion in neurobiology 17, 103-11.
55. Girard, S. L., Dion, P. A., and Rouleau, G. A. (2012). Schizophrenia genetics: putting all the pieces together. Current neurology and neuroscience reports 12, 261-6.
56. Girard, S. L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Dionne-Laporte, A., Spiegelman, D., Henrion, E., Diallo, O., et al. (2011). Increased exonic de novo mutation rate in individuals with schizophrenia. Nature genetics 43, 860-3.
57. Girirajan, S., and Eichler, E. E. (2010). Phenotypic variability and genetic susceptibility to genomic disorders. Human molecular genetics 19, R176-87.
58. Gizer, I. R., Ficks, C., and Waldman, I. D. (2009). Candidate gene studies of ADHD: a meta840 analytic review. Human genetics 126, 51-90.
59. Golzio, C., Willer, J., Talkowski, M. E., Oh, E. C., Taniguchi, Y., Jacquemont, S., Reymond, A., Sun, M., Sawa, A., Gusella, J. F., et al. (2012). KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 485, 363-7.
60. Gothelf, D., Presburger, G., Levy, D., Nahmani, A., Burg, M., Berant, M., Blieden, L. C., Finkelstein, Y., Frisch, A., Apter, A., et al. (2004). Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics 126B, 116-21.
61. Gottesman, I., and Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. The American journal of psychiatry 160, 636-45.
62. Guidry, J., and Kent, T. A. (1999). New genetic hypothesis of schizophrenia. Medical hypotheses 52, 69-75.
63. Hawi, Z., Dring, M., Kirley, A., Foley, D., Kent, L., Craddock, N., Asherson, P., Curran, S., Gould, A., Richards, S., et al. (2002). Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Molecular psychiatry 7, 718-25.
64. Higashijima, S., Masino, M. A., Mandel, G., and Fetcho, J. R. (2003). Imaging neuronal activity during zebrafish behavior with a genetically encoded calcium indicator. Journal of neurophysiology 90, 3986-97.
65. Huang, P., Xiao, A., Zhou, M., Zhu, Z., Lin, S., and Zhang, B. (2011). Heritable gene targeting in zebrafish using customized TALENs. Nature biotechnology 29, 699-700.
66. Irons, T. D., MacPhail, R. C., Hunter, D. L., and Padilla, S. (2010). Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicology and teratology 32, 84-90.
67. Iwase, S., Lan, F., Bayliss, P., De la Torre-Ubieta, L., Huarte, M., Qi, H. H., Whetstine, J. R., Bonni, A., Roberts, T. M., and Shi, Y. (2007). The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-88.
68. Kendler, K. S., and Neale, M. C. (2010). Endophenotype: a conceptual analysis. Molecular psychiatry 15, 789-97.
69. Knudson, A. G. (1971). Mutation and cancer: stat istical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 68, 820-3.
70. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C. Y., Mateus, R., Healey, D., Kim, S., Werdich, A. A., Haggarty, S. J., et al. (2010). Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nature chemical biology 6, 231-237.
71. Komoike, Y., Shimojima, K., Liang, J. S., Fujii, H., Maegaki, Y., Osawa, M., Fujii, S., Higashinakagawa, T., and Yamamoto, T. (2010). A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish. Journal of human genetics 55, 155-62.
72. Laggner, C., Kokel, D., Setola, V., Tolia, A., Lin, H., Irwin, J. J., Keiser, M. J., Cheung, C. Y., Minor, D. L., Roth, B. L., et al. (2012). Chemical informatics and target identification in a zebrafish phenotypic screen. Nature chemical biology 8, 144-6.
73. LaHoste, G. J., Swanson, J. M., Wigal, S. B., Glabe, C., Wigal, T., King, N., and Kennedy, J. L. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular psychiatry 1, 121-4.
74. Lange, M., Norton, W., Coolen, M., Chaminade, M., Merker, S., Proft, F., Schmitt, A., Vernier, P., Lesch, K. P., and Bally-Cuif, L. (2012). The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Molecular psychiatry. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22508465.
75. Laucht, M., Skowronek, M. H., Becker, K., Schmidt, M. H., Esser, G., Schulze, T. G., and Rietschel, M. (2007). Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Archives of general psychiatry 64, 585-90.
76. Lesch, K. P., Selch, S., Renner, T. J., Jacob, C., Nguyen, T. T., Hahn, T., Romanos, M., Walitza, S., Shoichet, S., Dempfle, A., et al. (2010). Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Molecular psychiatry. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Ci tation&list_uids=20308990.
77. Lesch, K. P., Timmesfeld, N., Renner, T. J., Halperin, R., Roser, C., Nguyen, T. T., Craig, D. W., Romanos, J., Heine, M., Meyer, J., et al. (2008). Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115, 1573-85.
78. Li, J., Wang, Y., Zhou, R., Zhang, H., Yang, L., Wang, B., and Faraone, S. V. (2007). Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 144B, 14-9.
79. Lillesaar, C., Stigloher, C., Tannhauser, B., Wullimann, M. F., and Bally-Cuif, L. (2009). Axonal projections originating from raphe serotonergic neurons in the developing and adult zebrafish, Danio rerio, us ing transgenics to visualize raphe-specific pet1 expression. The Journal of comparative neurology 512, 158-82.
80. Lin, S. L., Chang, S. J., and Ying, S. Y. (2006). First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Molecular psychiatry 11, 616-7.
81. Lionel, A. C., Crosbie, J., Barbosa, N., Goodale, T., Thiruvahindrapuram, B., Rickaby, J., Gazzellone, M., Carson, A. R., Howe, J. L., Wang, Z., et al. (2011). Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Science translational medicine 3, 95ra75.
82. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., and Grace, A. A. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in neurosciences 31, 234-42.
83. Lord, C., Cook, E. H., Leventhal, B. L., and Amaral, D. G. (2000). Autism spectrum disorders. Neuron 28, 355-63.
84. Lord, C. E. (2010). Autism: from research to practice. The American psychologist 65, 815-26.
85. Marks, C., West, T. N., Bagatto, B., and Moore, F. B.-G. (2005). Developmental environment alters conditional aggression in zebrafish. Copeia 4.
86. Menelaou, E., and Svoboda, K. R. (2009). Secondary motoneurons in juvenile and adult zebrafish: axonal pathfinding errors caused by embryonic nicotine exposure. The Journal of comparative neurology 512, 305-22.
87. Millar, J. K., Christie, S., Semple, C. A., and Porteous, D. J. (2000). Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics 67, 69-77.
88. Mitchell, K. (2011). The miswired brain: making connections from neurodevelopment to psychopathology. BMC Biology 9.
89. Mitchell, K., and Porteus, D. J. (2011). Rethinking the genetic architecture of schizophrenia. Psychological Medicine 41, 19-32.
90. Molina, B. S., and Pelham, W. E. (2003). Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of abnormal psychology 112, 497-507.
91. Morris, J. A. (2009). Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. Prog. Brain Res. 179, 97-106.
92. Mueser, K. T., and McGurk, S. R. (2004). Schizophrenia. Lancet 363, 2063-72.
93. Nagel, G., Szellas, T., Huhn, W., Kateriya, S., Adeishvili, N., Berthold, P., Ollig, D., Hegemann, P., and Bamberg, E. (2003). Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proceedings of the National Academy of Sciences of the United States of America 100, 13940-5.
94. Norton, W., and Bally-Cuif, L. (2010). Adult zebrafish as a model organism for behavioural genetics. BMC neuroscience 11, 90.
95. Norton, W. H., Stumpenhorst, K., Faus-Kessler, T., Folchert, A., Rohner, N., Harris, M. P., Callebert, J., and Bally-Cuif, L. (2011). Modulation of Fgfr1a signaling in zebrafish reveals a genetic basis for the aggression-boldness syndrome. J Neurosci 31, 13796-807.
96. O'Sullivan, M. L., De Wit, J., Savas, J. N., Comoletti, D., Otto-Hitt, S., Yates, J. R., and Ghosh, A. (2012). FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development. Neuron 73, 903-10.
97. Parker, M. O., Millington, M. E., Combe, F. J., and Brennan, C. H. (2012). Development and implementation of a three-choice serial reaction time task for zebrafish (Danio rerio). Behavioural brain research 227, 73-80.
98. Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., and Schacht, A. L. (2010). How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature reviews. Drug discovery 9, 203-14.
99. Peterson, R. T., Link, B. A., Dowling, J. E., and Schreiber, S. L. (2000). Small molecule developmental screens reveal the logic and timing of vertebrate development. Proceedings of the National Academy of Sciences of the United States of America 97, 12965-9.
100. Polanczyk, G., De Lima, M. S., Horta, B. L., Biederman, J., and Rohde, L. A. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. The American journal of psychiatry 164, 942-8.
101. Porteous, D. J., Millar, J. K., Brandon, N. J., and Sawa, A. (2011). DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends in molecular medicine 17, 699-706.
102. Purper-Ouakil, D., Wohl, M., Mouren, M. C., Verpillat, P., Ades, J., and Gorwood, P. (2005). Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatric genetics 15, 53-9.
103. Qi, H. H., Sarkissian, M., Hu, G. Q., Wang, Z., Bhattacharjee, A., Gordon, D. B., Gonzales, M., Lan, F., Ongusaha, P. P., Huarte, M., et al. (2010). Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466, 503-7.
104. De Rienzo, G., Bishop, J. A., Mao, Y., Pan, L., Ma, T. P., Moens, C. B., Tsai, L. H., and Sive, H. (2011). Disc1 regulates both {beta}-catenin-mediated and noncanonical Wnt signaling during vertebrate embryogenesis. Faseb J. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Ci tation&list_uids=21859895.
105. Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T., et al. (2010). Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science (New York, N. Y 327, 348-51.
106. Rommelse, N. N. (2008). Endophenotypes in t he genetic research of ADHD over the last decade: have they lived up to their expectations? Expert review of neurotherapeutics 8, 1425-9.
107. Rosenberg, R. E., Daniels, A. M., Law, J. K., Law, P. A., and Kaufmann, W. E. (2009). Trends in autism spectrum disorder diagnoses: 1994-2007. Journal of autism and developmental disorders 39, 1099-111.
108. Rubia, K. (2011). "Cool" inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus "hot" ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review. Biological psychiatry 69, e69-87.
109. Ryu, S., Mahler, J., Acampora, D., Holzschuh, J., Erhardt, S., Omodei, D., Simeone, A., and Driever, W. (2007). Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr Biol 17, 873-80.
110. Sallinen, V., Sundvik, M., Reenila, I., Peitsaro, N., Khrustalyov, D., Anichtchik, O., Toleikyte, G., Kaslin, J., and Panula, P. (2009). Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. Journal of neurochemistry 109, 403-15.
111. Sander, J. D., Cade, L., Khayter, C., Reyon, D., Peterson, R. T., Joung, J. K., and Yeh, J. R. (2011). Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nature biotechnology 29, 697-8.
112. Sarter, M., Hagan, J., and Dudchenko, P. (1992). Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacology 107, 144-59.
113. Schmidt, S., and Petermann, F. (2009). Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD). BMC psychiatry 9, 58.
114. Sebat, J. (2007). Major changes in our DNA lead to major changes in our thinking. Nature genetics 39, S3-5.
115. Sebat, J., Levy, D. L., and McCarthy, S. E. (2009). Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 25, 528-35.
116. Seibt, K. J., Oliveira Rda, L., Zimmermann, F. F., Capiotti, K. M., Bogo, M. R., Ghisleni, G., and Bonan, C. D. (2010). Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behavioural brain research 214, 417-22.
117. Seibt, K. J., Piato, A. L., Da Luz Oliveira, R., Capiotti, K. M., Vianna, M. R., and Bonan, C. D. (2011). Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio). Behavioural brain research 224, 135-9.
118. Sharp, S. I., McQuillin, A., and Gurling, H. M. (2009). Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57, 590-600.
119. Silva, J. P., Lelianova, V. G., Ermolyuk, Y. S., Vysokov, N., Hitchen, P. G., Berninghausen, O., Rahman, M. A., Zangrandi, A., Fidalgo, S., Tonevitsky, A. G., et al. (2011). Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proceedings of the National Academy of Sciences of the United States of America 108, 12113-8.
120. Singh, K. K., De Rienzo, G., Drane, L., Mao, Y., Flood, Z., Madison, J., Ferreira, M., Bergen, S., King, C., Sklar, P., et al. (2011). Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 72, 545-58.
121. Song, Y., Willer, J. R., Scherer, P. C., Panzer, J. A., Kugath, A., Skordalakes, E., Gregg, R. G., Willer, G. B., and Balice-Gordon, R. J. (2010). Neural and synaptic defects in slytherin, a zebrafish model for human congenital disorders of glycosylation. PloS one 5, e13743.
122. Souza, B. R., Romano-Silva, M. A., and Tropepe, V. (2011). Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae. The Journal of neuroscience: the official journal of the Society for Neuroscience 31, 5512-25.
123. Sullivan, P. F., Kendler, K. S., and Neale, M. C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of general psychiatry 60, 1187-92.
124. Svoboda, K. R., Vijayaraghavan, S., and Tanguay, R. L. (2002). Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. The Journal of neuroscience: the official journal of the Society for Neuroscience 22, 10731-41.
125. Swanson, J., Castellanos, F. X., Murias, M., LaHoste, G., and Kennedy, J. (1998). Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Current opinion in neurobiology 8, 263-71.
126. Sylvain, N. J., Brewster, D. L., and Ali, D. W. (2011). Embryonic ethanol exposure alters synaptic properties at zebrafish neuromuscular junctions. Neurotoxicology and teratology 33, 313-21.
127. Sylvain, N. J., Brewster, D. L., and Ali, D. W. (2010). Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. Neurotoxicology and teratology 32, 472-80.
128. Tal, T. L., Franzosa, J. A., Tilton, S. C., Philbrick, K. A., Iwaniec, U. T., Turner, R. T., Waters, K. M., and Tanguay, R. L. (2012). MicroRNAs control neurobehavioral development and function in zebrafish. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 1452-61.
129. Tarabeux, J., Champagne, N., Brustein, E., Hamdan, F. F., Gauthier, J., Lapointe, M., Maios, C., Piton, A., Spiegelman, D., Henrion, E., et al. (2010). De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biological psychiatry 68, 649-56.
130. Tay, T. L., Ronneberger, O., Ryu, S., Nitschke, R., and Driever, W. (2011). Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nature communications 2, 171.
131. Thapar, A., Rice, F., Hay, D., Boivin, J., Langley, K., Van den Bree, M., Rutter, M., and Harold, G. (2009). Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biological psychiatry 66, 722-7.
132. Thornton, G. K., and Woods, C. G. (2009). Primary microcephaly: do all roads lead to Rome? Trends Genet 25, 501-10.
133. Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., and Bourgeron, T. (2010). Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in genetics: TIG 26, 363-72.
134. Tropepe, V., and Sive, H. L. (2003). Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes, brain, and behavior 2, 268-81.
135. Tsend-Ayush, E., O'Sullivan, L. A., Grutzner, F. S., Onnebo, S. M., Lewis, R. S., Delbridge, M. L., Marshall Graves, J. A., and Ward, A. C. (2005). RBMX gene is essential for brain development in zebrafish. Developmental dynamics: an official publication of the American Association of Anatomists 234, 682-8.
136. Tucker, B., Richards, R. I., and Lardelli, M. (2006). Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. Human molecular genetics 15, 3446-58.
137. Valiente, M., and Marin, O. (2010). Neuronal migration mechanisms in development and disease. Current opinion in neurobiology 20, 68-78.
138. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., and Uhl, G. R. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-6.
139. Veleri, S., Bishop, K., Dalle Nogare, D. E., English, M. A., Foskett, T. J., Chitnis, A., Sood, R., Liu, P., and Swaroop, A. (2012). Knockdown of Bardet-Biedl syndrome gene BBS9/PTHB1 leads to cilia defects. PloS one 7, e34389.
140. Veltman, J. A., and Brunner, H. G. (2012). De novo mutations in human genetic disease. Nature reviews. Genetics 13, 565-75.
141. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F. P., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-14.
142. Walitza, S., Renner, T. J., Dempfle, A., Konrad, K., Wewetzer, C., Halbach, A., Herpertz-Dahlmann, B., Remschmidt, H., Smidt, J., Linder, M., et al. (2005). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Molecular psychiatry 10, 1126-32.
143. Wallis, D., Hill, D. S., Mendez, I. A., Abbott, L. C., Finnell, R. H., Wellman, P. J., and Setlow, B. (2012). Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain research 1463, 85-92.
144. Walsh, C. A. (1999). Genetic malformations of the human cerebral cortex. Neuron 23, 19-29.
145. Walsh, C. A., and Engle, E. C. (2010). Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron 68, 245-53.
146. Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539-43.
147. Weinberger, D. R. (1995). From neuropathology to neurodevelopment. Lancet 346, 552-7.
148. West-Eberhard, M. J. (2005). Developmental plasticity and the origin of species differences. Proceedings of the National Academy of Sciences of the United States of America 102 Suppl 1, 6543-9.
149. WHO, (World Health Organisation). (2008). The Global Burden of Disease. 2004 Update. WHO.
150. Williams, N. M., Zaharieva, I., Martin, A., Langley, K., Mantripragada, K., Fossdal, R., Stefansson, H., Stefansson, K., Magnusson, P., Gudmundsson, O. O., et al. (2010). Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376, 1401-8.
151. Wood, A. C., Rijsdijk, F., Asherson, P., and Kuntsi, J. (2009). Hyperactive-impulsive symptom scores and oppositional behaviours reflect alternate manifestations of a single liability. Behavior genetics 39, 447-60.
152. Xu, B., Roos, J. L., Levy, S., Van Rensburg, E. J., Gogos, J. A., and Karayiorgou, M. (2008). Strong association of de novo copy number mutations with sporadic schizophrenia. Nature genetics 40, 880-5.
153. Yoshida, T., and Mishina, M. (2008). Zebrafish orthologue of mental retardation protein IL1RAPL1 regulates presynaptic differentiation. Mol. Cell. Neurosci. 39, 218-228.
154. Zhang, F., Wang, L. P., Brauner, M., Liewald, J. F., Kay, K., Watzke, N., Wood, P. G., Bamberg, E., Nagel, G., Gottschalk, A., et al. (2007). Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-9.
155. Zweier, C., De Jong, E. K., Zweier, M., Orrico, A., Ousager, L. B., Collins, A. L., Bijlsma, E. K., Oortveld, M. A. W., Ekici, A. B., Reis, A., et al. (2009). CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am. J. Hum. Genet. 85, 655-666.